Index NDX, S&P 500
P/E -
EPS (ttm) -7.00
Insider Own 17.52%
Shs Outstand 863.67M
Perf Week -0.40%
Market Cap 15.12B
Forward P/E 5.53
EPS next Y 3.17
Insider Trans 0.00%
Shs Float 711.60M
Perf Month -5.24%
Income -6037.00M
PEG -
EPS next Q 0.72
Inst Own 59.17%
Short Float 5.46%
Perf Quarter -24.60%
Sales 144.60B
P/S 0.10
EPS this Y -18.91%
Inst Trans -0.06%
Short Ratio 3.32
Perf Half Y -16.84%
Book/sh 15.63
P/B 1.12
EPS next Y -1.70%
ROA -6.54%
Short Interest 38.88M
Perf Year -47.67%
Cash/sh 0.77
P/C 22.64
EPS next 5Y -7.67%
ROE -34.82%
52W Range 17.25 - 34.60
Perf YTD -32.86%
Dividend Est. 1.53 (8.71% )
P/FCF -
EPS past 5Y -
ROI -13.79%
52W High -49.34%
Beta 0.79
Dividend TTM 1.69 (9.64% )
Quick Ratio 0.32
Sales past 5Y 1.35%
Gross Margin 16.90%
52W Low 1.62%
ATR (14) 0.52
Dividend Ex-Date May 20, 2024
Current Ratio 0.66
EPS Y/Y TTM -92.32%
Oper. Margin 0.60%
RSI (14) 36.84
Volatility 2.28% 2.47%
Employees 331000
Debt/Eq 2.57
Sales Y/Y TTM 8.48%
Profit Margin -4.18%
Recom 3.10
Target Price 22.76
Option/Short Yes / Yes
LT Debt/Eq 2.25
EPS Q/Q -941.30%
Payout -
Rel Volume 0.67
Prev Close 17.34
Sales Surprise 3.32%
EPS Surprise 46.57%
Sales Q/Q 6.28%
Earnings Mar 28 BMO
Avg Volume 11.72M
Price 17.53
SMA20 -3.05%
SMA50 -11.25%
SMA200 -23.15%
Trades
Volume 7,855,568
Change 1.10%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$23
Feb-20-24 Downgrade
HSBC Securities
Hold → Reduce
Jan-03-24 Initiated
Barclays
Underweight
$21
Dec-22-23 Initiated
HSBC Securities
Hold
$27
Oct-23-23 Upgrade
JP Morgan
Neutral → Overweight
$27 → $30
Jul-03-23 Reiterated
Morgan Stanley
Underweight
$37 → $27
Jun-28-23 Downgrade
Deutsche Bank
Buy → Hold
$46 → $34
Feb-23-23 Initiated
Loop Capital
Buy
$45
Nov-23-22 Resumed
Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade
Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade
JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade
Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated
Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade
Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade
Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed
Credit Suisse
Neutral
$42
Apr-06-20 Upgrade
UBS
Sell → Neutral
$49 → $44
Apr-03-20 Upgrade
Deutsche Bank
Sell → Hold
$51 → $43
Show Previous Ratings
Today 05:50PM
01:00PM
11:45AM
10:10AM
04:00AM
05:30PM
Loading…
May-01-24 05:30PM
03:42PM
01:16PM
(The Wall Street Journal)
12:38PM
02:39AM
(Thomson Reuters StreetEvents)
Apr-30-24 04:20PM
04:01PM
08:30AM
08:06AM
06:00AM
03:00AM
Loading…
Apr-27-24 03:00AM
Apr-26-24 02:30PM
11:39AM
09:00AM
07:35AM
Apr-25-24 07:41PM
01:53PM
10:10AM
12:01AM
Apr-24-24 11:55PM
05:09PM
11:44AM
09:00AM
Apr-22-24 08:57AM
Apr-20-24 09:16AM
12:00PM
Loading…
Apr-18-24 12:00PM
10:56AM
Apr-17-24 09:00AM
Apr-16-24 10:45AM
05:21AM
Apr-15-24 06:31PM
08:00AM
Apr-12-24 12:58PM
12:56PM
Apr-11-24 05:34AM
Apr-10-24 04:42PM
09:53AM
07:45AM
Apr-09-24 03:38PM
10:45AM
Apr-07-24 05:35AM
03:00AM
Apr-04-24 01:44PM
09:00AM
08:40AM
Apr-03-24 01:48PM
11:34AM
08:45AM
Apr-02-24 10:45AM
Apr-01-24 05:29PM
04:34PM
03:47PM
12:38PM
01:11AM
Mar-31-24 02:17PM
08:35AM
Mar-30-24 01:00PM
Mar-29-24 04:54PM
12:29PM
01:01AM
12:35AM
(Thomson Reuters StreetEvents)
Mar-28-24 07:46PM
07:40PM
06:44PM
04:49PM
04:39PM
04:37PM
(The Wall Street Journal)
04:35PM
04:19PM
03:24PM
02:48PM
01:06PM
01:06PM
12:50PM
12:18PM
(Associated Press Finance)
11:53AM
11:34AM
11:32AM
11:24AM
11:06AM
(The Wall Street Journal)
10:54AM
10:47AM
(The Wall Street Journal)
10:38AM
10:06AM
09:43AM
09:32AM
(The Wall Street Journal)
09:30AM
08:38AM
08:31AM
08:21AM
08:15AM
08:10AM
08:02AM
07:20AM
07:20AM
(The Wall Street Journal)
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bhandari Inderpal S Director Apr 11 '24 Buy 18.05 3,000 54,150 3,000 Apr 15 05:45 PM Mahajan Manmohan EVP and Global CFO Apr 02 '24 Buy 19.38 6,000 116,280 166,969 Apr 02 06:40 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 07 '24 Sale 235.41 4,212,395 991,639,907 26,277,561 Feb 09 07:00 AM JARRETT VALERIE B Director Jan 29 '24 Buy 22.44 4,456 99,993 4,456 Jan 31 04:11 PM SCHLICHTING NANCY M Director Jan 16 '24 Sale 23.05 15,209 350,567 0 Jan 18 04:18 PM WENTWORTH TIMOTHY C Chief Executive Officer Jan 05 '24 Buy 24.22 10,000 242,220 585,122 Jan 08 07:29 AM Gates Richard P. SVP, Chief Pharmacy Officer Nov 10 '23 Sale 20.45 1,000 20,450 73,929 Nov 14 08:22 PM Walgreens Boots Alliance, Inc. 10% Owner Nov 09 '23 Sale 195.38 1,279,590 249,999,896 30,489,956 Nov 14 07:15 AM Walgreens Boots Alliance, Inc. 10% Owner Aug 03 '23 Sale 189.27 1,320,858 250,000,115 31,769,546 Aug 07 05:48 PM DRISCOLL JOHN PATRICK EVP, Pres. U.S. Healthcare Jun 30 '23 Buy 28.42 5,172 146,984 59,050 Jul 05 06:57 PM Walgreens Boots Alliance, Inc. 10% Owner Jun 15 '23 Sale 181.17 275,984 50,000,021 33,090,404 Jun 20 06:03 AM Walgreens Boots Alliance, Inc. 10% Owner May 11 '23 Sale 170.77 292,792 50,000,090 33,366,388 May 15 05:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite